Home › Business › Pharmaceuticals News
Latest Stories 
Pfizer gets $1.38B patent settlement
June 13, 2013
Pfizer Inc. will receive about $1.38 billion in a settlement with Teva Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries Ltd. over a nearly decade-old patent case, the company said Wednesday.
The total settlement, to be...
(0)
Former Pfizer workers eligible for federal benefits
June 13, 2013
About 20 former Pfizer Inc. employees and contractors in Groton have been certified as eligible for federal benefits because their jobs were sent overseas, the state Department of Labor said Wednesday.
Workers associated with Pfizer's...
(4)
More Pfizer jobs go overseas
June 12, 2013
Pfizer Inc. announced today that it will receive about $1.38 billion in a settlement with Teva Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries Ltd. over a nearly decade-old patent case. Pfizer Inc. is partnering with a San Francisco firm to discover next-generation cancer treatments. The drug-industry blog FiercePharma reported this week that Pfizer has agreed to pay CytomX Therapeutics $25 million up front and as much as... PFIZER, UNIVERSITY EXPAND PARTNERSHIP Pfizer Inc. has expanded a drug-development partnership with the University of California at San Francisco. According to UCSF, the expansion of Pfizer's Centers for Therapeutic... Pfizer Inc. announced this week that its Groton laboratories will be supporting 30 organizations in southeastern Connecticut, New Haven and Rhode Island through its competitive grants program. Organizations can apply online for the... Pfizer Inc. has announced the closure of an Irish production plant that will lead to 136 job cuts. The New York-based drug giant said the closure of its Little Island manufacturing plant in Cork was the result of "changing global demand"... Nearly 400 former workers at Pfizer Inc., including some who were working at the Groton laboratories as contractors for ExecuPharm Inc., have been told they qualify for federal benefits after their jobs were moved overseas. The U.S. Dublin-based biotech Amarin Corp. plc's stock took a ride upward Friday, one day after releasing first-quarter financial results that gave an early glimpse of how sales of its newly approved heart medication, Vascepa, are proceeding. Pfizer Inc. is inviting investors and the public to attend a webcast at 11 a.m. today in which Mikael Dolsten, president of its research-and-development division worldwide, speaks during the Morgan Stanley 2013 R&D Seminar called Reigniting... Senior managers of Amarin Corp. plc, a biotech company with research headquarters in Groton, will discuss the company's first-quarter financial results at 4:30 p.m. Thursday during a conference call. To participate in the call, dial... New drugs spurred along by research at Pfizer Inc. laboratories in Groton couldn't provide enough lift to make up for losses in the company's established portfolio as the firm announced disappointing first-quarter financial results... Drug giant Pfizer Inc. has joined forces with competitor Merck & Co. Inc. to co-develop a new medicine for patients with type 2 diabetes, the companies announced Monday. Pfizer, which has a research-and-development site in Groton, currently... Pfizer Inc. reported disappointing first-quarter financial results this morning, with dramatically increased profits failing to mask weaknesses in pharmaceutical sales. Amarin Corp. plc, the Irish drug company with research headquarters in Groton, announced Tuesday that U.S. regulators have agreed to review its fish-oil medication Vascepa for an expanded group of patients not covered by similar prescription...
(6)
Pfizer shares $2.15 billion patent settlement June 12, 2013 (0)
PFIZER IN PARTNERSHIP FOR CANCER RESEARCH June 8, 2013 (0)
Pfizer expands drug deal with UCSF June 5, 2013 (0)
Genomic lab lures Harvard researcher May 24, 2013 (0)
Pfizer announces community grants May 23, 2013 (0)
Pfizer closing Irish plant May 18, 2013 (0)
Feds offer more benefits to 390 laid-off Pfizer workers May 17, 2013 (5)
Quarterly sends Amarin stock soaring May 11, 2013 (3)
Drugs falling out of patent mean savings May 10, 2013 (0)
Pfizer R&D webcast today May 10, 2013 (0)
Amarin managers to discuss finances May 8, 2013 (0)
Pfizer's first-quarter revenues disappoint May 1, 2013 (1)
Pfizer and Merck partner to develop diabetes drug April 30, 2013 (0)
Pfizer’s first-quarter results disappoint Wall Street April 30, 2013 (1)
Pfizer declares 24-cent dividend April 27, 2013
(0)
Europe rejects Pfizer arthritis drug
April 27, 2013 (0)
Amarin gets renewed drug application April 24, 2013 (3)
Popular on theday.com
Most-Read Stories
Most-Viewed Multimedia
Most-Discussed Stories
-
New London firefighter Mayo charged with assault, breach of peace Friday night (55)
-
Demand for gun permits taxes Groton police policy (52)
-
Newtown families deliver a message to Congress (50)
-
Workers, public officials protest closure of AT&T call center in New London (44)
- Texas governor visiting Connecticut (42)
-
Rep. Ernest Hewett has put the snake incident behind him (28)
-
Newtown activists bring anti-gun message to Congress (28)
-
When traffic backs up on Interstate 95, everybody suffers (28)
Interact
Most Recent Poll
News & Features
MORE
860-442-2200
The Day Publishing Company
New London, CT USA
Copyright © 1998